Hjem › Venstriket dysfunktion › Texas › Dallas
Venstriket dysfunktion kliniske forsøg i Dallas, TX
3 studier for Venstriket dysfunktion søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RekruttererFase 2/3
- Children's Health-The Heart Center ( Site 0015), Dallas
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
RekruttererFase 3
- Children's Medical Center Dallas - Cardiology, Dallas
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
RekruttererFase 3
- Children's Medical Center Dallas - Cardiology, Dallas
Venstriket dysfunktion forsøg i andre byer
- Cleveland, OH4 studier
- New York City, NY4 studier
- Houston, TX3 studier
- The Bronx, NY3 studier
- Cincinnati, OH3 studier
- Pittsburgh, PA3 studier
- Philadelphia, PA3 studier
- Boston, MA3 studier
- Ann Arbor, MI3 studier
- Aurora, CO3 studier
- St. Louis, MO3 studier
- Atlanta, GA3 studier
Andre studier i Dallas
- Brystkræft55 studier
- Ikke-småcellet lungecancer52 studier
- Metastatisk cancer42 studier
- Hjertesvigt42 studier
- Kræft (alle typer)37 studier
- Prostatakræft36 studier
- Colorektal kræft33 studier
- Overvægt30 studier
- Ægstockræft28 studier
- Blærecancer27 studier
- Lungecancer27 studier
- Livmoderslimhindekræft24 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.